Sanofi India Investor Presentation: Key Takeaways
Sanofi India reported Q2'26 domestic sales growth of 8% YoY, driven by a 14% surge in its diabetes business. Management is focusing on business model transformation and operational efficiency.
- Call
- Guides 17% growth